APO RESEARCH · REPORT
Nitric Oxide Therapy System
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Product & engineering
Understand the product.
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Selected research
Industry Research
Nitric Oxide Therapy System Industry Research Report 2026
Market perspective
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
Report Scope
Read the full market overview
This report quantifies the global Nitric Oxide Therapy System market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nitric Oxide Therapy System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nitric Oxide Therapy System Market by Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Nitric Oxide Therapy System Segment by Type
Protable System
Fixed System
Nitric Oxide Therapy System Segment by Application
Hospitals
Homecare Settings
Others
Nitric Oxide Therapy System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitric Oxide Therapy System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitric Oxide Therapy System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitric Oxide Therapy System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nitric Oxide Therapy System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protable System
- Fixed System
Applications
- Hospitals
- Homecare Settings
- Others
Companies covered
- Bellerophon Therapeutics
- BOC Healthcare
- Dan Hammer Health
- EKU Elektronik GmbH
- GeNO LLC
- International Biomedical
- SLE
- Mallinckrodt Pharmaceuticals
- Praxair,
- Vapotherm
- Linde Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nitric Oxide Therapy System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Protable System
- 2.2.3 Fixed System
- 2.3 Nitric Oxide Therapy System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Homecare Settings
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Nitric Oxide Therapy System Breakdown Data by Type
- 3.1 Global Nitric Oxide Therapy System Historic Market Size by Type (2021-2026)
- 3.2 Global Nitric Oxide Therapy System Forecasted Market Size by Type (2027-2032)
4 Nitric Oxide Therapy System Breakdown Data by Application
- 4.1 Global Nitric Oxide Therapy System Historic Market Size by Application (2021-2026)
- 4.2 Global Nitric Oxide Therapy System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nitric Oxide Therapy System Market Perspective (2021-2032)
- 5.2 Global Nitric Oxide Therapy System Growth Trends by Region
- 5.2.1 Global Nitric Oxide Therapy System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nitric Oxide Therapy System Historic Market Size by Region (2021-2026)
- 5.2.3 Nitric Oxide Therapy System Forecasted Market Size by Region (2027-2032)
- 5.3 Nitric Oxide Therapy System Market Dynamics
- 5.3.1 Nitric Oxide Therapy System Industry Trends
- 5.3.2 Nitric Oxide Therapy System Market Drivers
- 5.3.3 Nitric Oxide Therapy System Market Challenges
- 5.3.4 Nitric Oxide Therapy System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nitric Oxide Therapy System Players by Revenue
- 6.1.1 Global Top Nitric Oxide Therapy System Players by Revenue (2021-2026)
- 6.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Players (2021-2026)
- 6.2 Global Nitric Oxide Therapy System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nitric Oxide Therapy System Head Office and Area Served
- 6.4 Global Nitric Oxide Therapy System Players, Product Type & Application
- 6.5 Global Nitric Oxide Therapy System Manufacturers Established Date
- 6.6 Global Nitric Oxide Therapy System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nitric Oxide Therapy System Market Size (2021-2032)
- 7.2 North America Nitric Oxide Therapy System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 7.4 North America Nitric Oxide Therapy System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nitric Oxide Therapy System Market Size (2021-2032)
- 8.2 Europe Nitric Oxide Therapy System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 8.4 Europe Nitric Oxide Therapy System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nitric Oxide Therapy System Market Size (2021-2032)
- 9.2 Asia-Pacific Nitric Oxide Therapy System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nitric Oxide Therapy System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nitric Oxide Therapy System Market Size (2021-2032)
- 10.2 South America Nitric Oxide Therapy System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 10.4 South America Nitric Oxide Therapy System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nitric Oxide Therapy System Market Size (2021-2032)
- 11.2 Middle East & Africa Nitric Oxide Therapy System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nitric Oxide Therapy System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bellerophon Therapeutics
- 12.1.1 Bellerophon Therapeutics Company Information
- 12.1.2 Bellerophon Therapeutics Business Overview
- 12.1.3 Bellerophon Therapeutics Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio
- 12.1.5 Bellerophon Therapeutics Recent Developments
- 12.2 BOC Healthcare
- 12.2.1 BOC Healthcare Company Information
- 12.2.2 BOC Healthcare Business Overview
- 12.2.3 BOC Healthcare Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.2.4 BOC Healthcare Nitric Oxide Therapy System Product Portfolio
- 12.2.5 BOC Healthcare Recent Developments
- 12.3 Dan Hammer Health
- 12.3.1 Dan Hammer Health Company Information
- 12.3.2 Dan Hammer Health Business Overview
- 12.3.3 Dan Hammer Health Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.3.4 Dan Hammer Health Nitric Oxide Therapy System Product Portfolio
- 12.3.5 Dan Hammer Health Recent Developments
- 12.4 EKU Elektronik GmbH
- 12.4.1 EKU Elektronik GmbH Company Information
- 12.4.2 EKU Elektronik GmbH Business Overview
- 12.4.3 EKU Elektronik GmbH Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio
- 12.4.5 EKU Elektronik GmbH Recent Developments
- 12.5 GeNO LLC
- 12.5.1 GeNO LLC Company Information
- 12.5.2 GeNO LLC Business Overview
- 12.5.3 GeNO LLC Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.5.4 GeNO LLC Nitric Oxide Therapy System Product Portfolio
- 12.5.5 GeNO LLC Recent Developments
- 12.6 International Biomedical
- 12.6.1 International Biomedical Company Information
- 12.6.2 International Biomedical Business Overview
- 12.6.3 International Biomedical Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.6.4 International Biomedical Nitric Oxide Therapy System Product Portfolio
- 12.6.5 International Biomedical Recent Developments
- 12.7 SLE
- 12.7.1 SLE Company Information
- 12.7.2 SLE Business Overview
- 12.7.3 SLE Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.7.4 SLE Nitric Oxide Therapy System Product Portfolio
- 12.7.5 SLE Recent Developments
- 12.8 Mallinckrodt Pharmaceuticals
- 12.8.1 Mallinckrodt Pharmaceuticals Company Information
- 12.8.2 Mallinckrodt Pharmaceuticals Business Overview
- 12.8.3 Mallinckrodt Pharmaceuticals Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio
- 12.8.5 Mallinckrodt Pharmaceuticals Recent Developments
- 12.9 Praxair,
- 12.9.1 Praxair, Company Information
- 12.9.2 Praxair, Business Overview
- 12.9.3 Praxair, Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.9.4 Praxair, Nitric Oxide Therapy System Product Portfolio
- 12.9.5 Praxair, Recent Developments
- 12.10 Vapotherm
- 12.10.1 Vapotherm Company Information
- 12.10.2 Vapotherm Business Overview
- 12.10.3 Vapotherm Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.10.4 Vapotherm Nitric Oxide Therapy System Product Portfolio
- 12.10.5 Vapotherm Recent Developments
- 12.11 Linde Group
- 12.11.1 Linde Group Company Information
- 12.11.2 Linde Group Business Overview
- 12.11.3 Linde Group Revenue in Nitric Oxide Therapy System Business (2021-2026)
- 12.11.4 Linde Group Nitric Oxide Therapy System Product Portfolio
- 12.11.5 Linde Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst